Medical device developer Hancock Jaffe Laboratories (NASDAQ:HJLI) has seen its share price jump after the company announced follow-up data on its VenoValve patients.
HJLI’s shares are currently trading at $0.58 per share, up 106.55%.
The VenoValve is a valve designed to provide surgeons with a surgical option to treat chronic deep venous insufficiency.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Two additional patients from the company’s study in Colombia have now reached the one-year milestone following the VenoValve surgery, with chronic venous insufficiency improving.
The results showed that the “chronic venous insufficiency (“CVI”) has significantly improved in both patients when compared to pre-surgery levels,” stated the company in its press release.
The eight VenoValve patients from the original study have now completed the one-year human trial. Hancock said that the Venous Clinical Severity Scores (VCSS) have improved on average 42% among the patients.
Dr Marc H. Glickman, Hancock Jaffe’s Senior Vice President and Chief Medical Officer stated, “An 8 point average decrease in VCSS scores after one-year post-surgery is a significant improvement that will garner a lot of attention among the vascular community. It is extremely gratifying when as a result of the VenoValve, the pain score, that is graded on a scale, of one to ten, goes from an 8 pre-surgery to 1 at one year post VenoValve surgery, for an 86 year old patient that has suffered from severe CVI for more than 30 years.”
